SG10201500283UA - Use of methylsulfonylmethane (msm) to modulate microbial activity - Google Patents
Use of methylsulfonylmethane (msm) to modulate microbial activityInfo
- Publication number
- SG10201500283UA SG10201500283UA SG10201500283UA SG10201500283UA SG10201500283UA SG 10201500283U A SG10201500283U A SG 10201500283UA SG 10201500283U A SG10201500283U A SG 10201500283UA SG 10201500283U A SG10201500283U A SG 10201500283UA SG 10201500283U A SG10201500283U A SG 10201500283UA
- Authority
- SG
- Singapore
- Prior art keywords
- methylsulfonylmethane
- msm
- microbial activity
- modulate microbial
- modulate
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N41/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom
- A01N41/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a sulfur atom bound to a hetero atom containing a sulfur-to-oxygen double bond
- A01N41/10—Sulfones; Sulfoxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
- C12N1/18—Baker's yeast; Brewer's yeast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/06—Ethanol, i.e. non-beverage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/56—Lactic acid
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/30—Fuel from waste, e.g. synthetic alcohol or diesel
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Botany (AREA)
- Dermatology (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Environmental Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25693509P | 2009-10-30 | 2009-10-30 | |
US25775109P | 2009-11-03 | 2009-11-03 | |
US25909809P | 2009-11-06 | 2009-11-06 | |
US29443710P | 2010-01-12 | 2010-01-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201500283UA true SG10201500283UA (en) | 2015-03-30 |
Family
ID=43922597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG10201500283UA SG10201500283UA (en) | 2009-10-30 | 2010-10-29 | Use of methylsulfonylmethane (msm) to modulate microbial activity |
Country Status (15)
Country | Link |
---|---|
US (7) | US20110105623A1 (fr) |
EP (2) | EP2493464B8 (fr) |
JP (2) | JP5651186B2 (fr) |
KR (2) | KR101826531B1 (fr) |
CN (2) | CN102724973B (fr) |
AU (2) | AU2010313228B2 (fr) |
BR (2) | BR112012010270A2 (fr) |
CA (2) | CA2778144C (fr) |
DK (2) | DK2494059T3 (fr) |
ES (2) | ES2616630T3 (fr) |
IL (2) | IL219321A (fr) |
MX (3) | MX2012005159A (fr) |
NZ (2) | NZ600145A (fr) |
SG (1) | SG10201500283UA (fr) |
WO (2) | WO2011053848A1 (fr) |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1966229B1 (fr) | 2005-09-12 | 2015-10-21 | Abela Pharmaceuticals, Inc. | Systèmes d'élimination de diméthylsulfoxyde (dmso), composés connexes ou odeurs associées à cette substance |
US8435224B2 (en) * | 2005-09-12 | 2013-05-07 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds |
EP2324838A1 (fr) | 2005-09-12 | 2011-05-25 | Abela Pharmaceuticals, Inc. | Compositions comprenant du diméthylsulfoxyde |
BRPI0921494A2 (pt) * | 2008-11-03 | 2018-10-30 | Prad Reasearch And Development Ltd | método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração. |
CA2779111C (fr) | 2009-10-30 | 2019-08-13 | Abela Pharmaceuticals, Inc. | Preparations a base de dimethylsulfoxyde (dmso) et de methylsulfonylmethane (msm) utilisees pour traiter l'arthrose |
JP5651186B2 (ja) | 2009-10-30 | 2015-01-07 | バイオジェニック イノベーションズ, リミテッド ライアビリティ カンパニー | 薬剤耐性微生物を処置するためのメチルスルホニルメタン(msm) |
WO2011123695A1 (fr) * | 2010-03-31 | 2011-10-06 | Abela Pharmaceuticals, Inc. | Formulations de diméthylsulfoxyde (dmso) pour traiter l'autisme |
RU2446815C1 (ru) * | 2011-03-03 | 2012-04-10 | Общество С Ограниченной Ответственностью "Парафарм" | Биологически активная добавка к пище для нормализации функции щитовидной железы |
EP2694834B2 (fr) * | 2011-03-09 | 2022-04-06 | Baum, Marc Michael | Préparations, procédés et systèmes de défrisage des cheveux à base de kératine |
US20120244362A1 (en) | 2011-03-22 | 2012-09-27 | Pramanik Pranabes K | Multi-layer sheet structure |
US8932656B1 (en) | 2011-09-20 | 2015-01-13 | Aja Henderson | Oil blend for skin treatment |
US9446089B1 (en) | 2011-09-20 | 2016-09-20 | Aja Henderson | Oil blend for skin treatment |
US9717757B1 (en) | 2011-12-28 | 2017-08-01 | Samuel N. Gasque, Jr. | Composition and method to treat and prevent muscle cramping |
KR101381794B1 (ko) * | 2012-04-10 | 2014-04-07 | 씨제이제일제당 (주) | 타가토스 및 프로바이오틱 유산균을 함유하는 신바이오틱 식품 조성물 |
US11931393B2 (en) * | 2012-04-10 | 2024-03-19 | Parapharm Llc | Biologically active food additive for normalizing the function of the thyroid gland |
RU2525426C2 (ru) * | 2012-07-16 | 2014-08-10 | Государственное научное учреждение Научно-исследовательский ветеринарный институт Нечерноземной зоны Российской Федерации Российской академии сельскохозяйственных наук | Способ коррекции вторичных иммунодефицитов у телят |
CA2934448A1 (fr) * | 2012-12-20 | 2014-06-26 | Rajiv Bhushan | Compositions antimicrobiennes |
KR101460777B1 (ko) | 2013-03-04 | 2014-11-19 | 주식회사 씨앤피코스메틱스 | 여드름 개선용 화장료 조성물 |
US9484589B1 (en) * | 2013-08-13 | 2016-11-01 | The United States Of America As Represented By Secretary Of The Navy | Microbial fuel cell with sediment agitator |
CN103435151B (zh) * | 2013-08-20 | 2014-10-08 | 珠海市德莱环保科技有限公司 | 提高废水好氧微生物降解cod能力的生物增强剂及方法 |
GB2521632B (en) * | 2013-12-23 | 2020-12-16 | Linscott Goode Steven | Vermin control compositions |
US20150328139A1 (en) * | 2014-05-15 | 2015-11-19 | Keith Marz | Orally Ingested or Topically Applied Skin Health and Nutrition Product |
US10766799B2 (en) * | 2014-05-23 | 2020-09-08 | Nch Corporation | Method for improving quality of aquaculture pond water using a nutrient germinant composition and spore incubation method |
KR101814967B1 (ko) | 2014-09-30 | 2018-01-04 | 킴벌리-클라크 월드와이드, 인크. | 크레이프된 프리바이오틱 티슈 |
CN107072941B (zh) | 2014-09-30 | 2020-10-13 | 金伯利-克拉克环球有限公司 | 协同益生元组合物 |
CN113667584A (zh) * | 2015-04-23 | 2021-11-19 | Bd科斯特公司 | 菌落对比度收集 |
WO2016210074A1 (fr) * | 2015-06-23 | 2016-12-29 | Carrie D. Alspaugh, M.D., P.A. | Compositions de désinfectant de main |
RU2577816C1 (ru) * | 2015-07-10 | 2016-03-20 | Олег Иванович Квасенков | Способ получения хлебного кваса |
RU2577973C1 (ru) * | 2015-07-13 | 2016-03-20 | Олег Иванович Квасенков | Способ получения хлебного кваса |
RU2590146C1 (ru) * | 2015-07-14 | 2016-07-10 | Олег Иванович Квасенков | Способ получения хлебного кваса |
RU2590147C1 (ru) * | 2015-07-14 | 2016-07-10 | Олег Иванович Квасенков | Способ получения хлебного кваса |
RU2590148C1 (ru) * | 2015-07-14 | 2016-07-10 | Олег Иванович Квасенков | Способ получения хлебного кваса |
US20170156289A1 (en) * | 2015-12-04 | 2017-06-08 | Woojo Chung | Gait Helper |
US10327480B2 (en) * | 2015-12-21 | 2019-06-25 | Misbah Khan | Disposable liners for body areas |
KR101948772B1 (ko) * | 2016-01-26 | 2019-05-10 | 김양희 | 표고버섯 재배 방법 |
JP2019510037A (ja) | 2016-03-31 | 2019-04-11 | ゴジョ・インダストリーズ・インコーポレイテッド | 抗菌ペプチド刺激性洗浄組成物 |
EP3436041B1 (fr) | 2016-03-31 | 2023-05-24 | Gojo Industries, Inc. | Composition de désinfectant contenant un probiotique/prébiotique en tant que principe actif |
KR102498391B1 (ko) | 2016-04-05 | 2023-02-13 | 엔씨에이취 코오포레이션 | 영양소 풍부 발아 조성물 및 포자 배양 방법 |
US10897922B2 (en) | 2016-04-05 | 2021-01-26 | Nch Corporation | Composition and method for germinative compounds in probiotic food and beverage products for human consumption |
ITUA20162680A1 (it) * | 2016-04-18 | 2017-10-18 | Univ Degli Studi Cagliari | Composti sulfamidici e/o tiosolfonici anti-batterici per l’utilizzo nel trattamento del virus herpes 8 in fase latente |
US11384032B2 (en) | 2016-05-12 | 2022-07-12 | Verdesian Life Sciences, U.S., Llc | Compositions for controlling enzyme-induced urea decomposition |
US10076551B2 (en) | 2016-11-14 | 2018-09-18 | FREDRICK COBBLE, Jr. | Method for treating interstitial lung disease |
EP3544575A1 (fr) | 2016-11-23 | 2019-10-02 | GOJO Industries, Inc. | Composition désinfectante comprenant une substance active probiotique/prébiotique |
KR101878599B1 (ko) * | 2017-03-28 | 2018-07-13 | 전북대학교산학협력단 | 메틸설포닐메테인과 만니톨의 흡수촉진 및 고미감소를 위한 공침조성물과 이의 제조방법 |
WO2018183562A1 (fr) | 2017-03-28 | 2018-10-04 | Verdesian Life Sciences, U.S., Llc | Compositions de triarylméthane pour réguler la décomposition d'urée induite par des enzymes |
US20180333349A1 (en) | 2017-05-17 | 2018-11-22 | Colgate-Palmolive Company | Oral Care Compositions and Methods of Use |
CA3057429A1 (fr) * | 2017-05-17 | 2018-11-22 | Colgate-Palmolive Company | Compositions de soins buccaux comprenant de l'huile de chanvre et du caprylyl glycol |
KR102065848B1 (ko) * | 2017-07-05 | 2020-01-13 | 고려대학교 산학협력단 | 엔테로코코스 카니테스티니(Enterococcus canintestini)균주를 함유하는 항인플루엔자 바이러스 조성물 |
WO2019032493A1 (fr) * | 2017-08-08 | 2019-02-14 | Valent Biosciences Llc | Formulations granulaires de rhizobium et de mycorhize et mélanges associés |
JP7135079B2 (ja) * | 2017-09-21 | 2022-09-12 | サミ-サビンサ グループ リミテッド | バチルス・コアグランスを含有するアルコール飲料組成物 |
WO2019104249A1 (fr) * | 2017-11-22 | 2019-05-31 | Progeneron | Compositions topiques, leur procédé de fabrication et leur procédé d'utilisation |
US11564963B2 (en) | 2017-11-22 | 2023-01-31 | Progeneron, Llc | Topical compositions, process of large-scale manufacture, and method of use |
CN107937290B (zh) * | 2017-12-15 | 2021-01-19 | 北京工商大学 | 一株用于水果采后病害防治的拜耳接合酵母及其制备方法与用途 |
KR102050286B1 (ko) * | 2018-02-08 | 2019-12-02 | 전북대학교산학협력단 | 건강기능식품 및 이의 제조방법 |
US10792320B2 (en) * | 2018-03-28 | 2020-10-06 | Michael Alan Beller | Methods for treatment of bladder dysfunction |
CN108342324A (zh) * | 2018-04-10 | 2018-07-31 | 中盐工程技术研究院有限公司 | 一种小球藻保存方法 |
CN108707568A (zh) * | 2018-06-13 | 2018-10-26 | 河北康泰药业有限公司 | 一种混合益生菌的发酵生产方法 |
US11905286B2 (en) | 2018-08-09 | 2024-02-20 | Antabio Sas | Diazabicyclooctanones as inhibitors of serine beta-lactamases |
CN111265502B (zh) * | 2018-12-05 | 2022-05-20 | 中国医学科学院药物研究所 | 香紫苏醇和香紫苏内酯在抗丝状病毒感染中的应用 |
WO2020210784A1 (fr) | 2019-04-12 | 2020-10-15 | Ecolab Usa Inc. | Nettoyant antimicrobien multi-usages et procédés de fabrication et d'utilisation de celui-ci |
CN110172420B (zh) * | 2019-05-15 | 2022-03-01 | 福建省农业科学院农业工程技术研究所 | 一株鼠李糖乳杆菌及其应用 |
WO2020237244A1 (fr) * | 2019-05-23 | 2020-11-26 | Professional Compounding Centers Of America, Inc. | Composition améliorant la perméation cutanée |
RU2723907C1 (ru) * | 2019-12-27 | 2020-06-18 | Сергей Александрович Савчук | Способ идентификации наркотических и психоактивных веществ в биосубстрате человека |
WO2021159068A1 (fr) | 2020-02-06 | 2021-08-12 | Nch Corportion | Composition et méthode d'utilisation des composés germinatifs dans les probiotiques pour réduire l'inflammation chez les êtres humains |
AU2021254780A1 (en) * | 2020-04-16 | 2022-10-20 | Atossa Therapeutics, Inc. | Compositions and methods to reduce the infectivity of a virus |
KR20220000029A (ko) | 2020-06-24 | 2022-01-03 | 주식회사 해피마스타 | 면역력 증강을 위한 건강 기능 식품 및 그 조성물 |
CN112098384B (zh) * | 2020-09-22 | 2023-09-01 | 华东交通大学 | 一种快速预测水质是否生物稳定的简捷方法 |
CN112237551A (zh) * | 2020-11-13 | 2021-01-19 | 深圳市薇美经典科技发展有限公司 | 一种修复护肤制剂制备方法 |
CN112220966A (zh) * | 2020-11-23 | 2021-01-15 | 北京大学口腔医学院 | 一种注射剂、注射剂的制备方法及其在牙髓再生中的应用 |
CN112516117A (zh) * | 2020-11-30 | 2021-03-19 | 中国人民解放军陆军特色医学中心 | Msm在制备破坏细胞壁及脏器保护药物中的应用 |
IN202041055641A (fr) * | 2020-12-21 | 2021-11-19 | ||
CN113009051A (zh) * | 2021-02-22 | 2021-06-22 | 中国食品药品检定研究院 | 肠道病毒71型灭活疫苗中β-内酰胺类抗生素的检测方法 |
CN113057933A (zh) * | 2021-04-04 | 2021-07-02 | 山西医科大学 | 一种维护和重塑皮肤微生态的润肤剂及制备方法 |
US20220362126A1 (en) * | 2021-05-13 | 2022-11-17 | Mark A. Foglietti | Cosmetic composition and method |
US20230058302A1 (en) * | 2021-08-03 | 2023-02-23 | Purina Animal Nutrition Llc | Products and methods for inhibiting respiratory conditions |
CN114480167B (zh) * | 2021-12-23 | 2024-01-12 | 美益添生物医药(武汉)有限公司 | 乳酸乳球菌md-622及其应用 |
WO2023157003A1 (fr) * | 2022-02-16 | 2023-08-24 | Yeda Research And Development Co. Ltd. | Procédés de raccourcissement de la durée de phase de latence dans des micro-organismes |
CN114965766B (zh) * | 2022-05-20 | 2024-03-08 | 重庆市食品药品检验检测研究院 | 豆瓣酱中有害污染源的评估方法 |
CN114794029B (zh) * | 2022-06-09 | 2023-02-28 | 上海大学 | 一种计数秀丽隐杆线虫子宫内发育胚胎数目的方法 |
CN115517166B (zh) * | 2022-10-21 | 2023-10-10 | 玉溪中烟种子有限责任公司 | 一种高活力液体负载复合花粉的制备及授粉应用方法 |
CN117363529A (zh) * | 2023-06-27 | 2024-01-09 | 深圳市波尔顿科技有限公司 | 具有肠炎治疗作用的鼠李糖乳杆菌及其应用 |
CN117126906A (zh) * | 2023-07-13 | 2023-11-28 | 中国农业大学 | 大豆分离蛋白的改性方法、改性大豆分离蛋白及其应用 |
Family Cites Families (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3654165A (en) * | 1970-09-10 | 1972-04-04 | Stanley Charles Bryant | Telephone cleaner-sanitizer |
US4333922A (en) * | 1974-09-12 | 1982-06-08 | Herschler R J | Method for the treatment of water-living animals with health modifying agents |
US4559329A (en) * | 1982-09-14 | 1985-12-17 | Herschler R J | Dietary and pharmaceutical uses of methyl-sulfonylmethane and compositions comprising it |
US4863748A (en) * | 1979-08-30 | 1989-09-05 | Herschler R J | Dietary products and uses comprising methylsulfonylmethane |
US4296130A (en) * | 1979-08-30 | 1981-10-20 | Herschler R J | Methylsulfonylmethane and methods of use |
US4514421A (en) * | 1979-08-30 | 1985-04-30 | Herschler R J | Dietary and pharmaceutical uses of methylsulfonylmethane and compositions comprising it |
US4914135A (en) * | 1979-08-30 | 1990-04-03 | Herschler R J | Use of Methylsulfonylmethane to treat parasitic infections |
US4973605A (en) * | 1979-08-30 | 1990-11-27 | Herschler R J | Use of methylsulfonylmethane to relieve pain and relieve pain and nocturnal cramps and to reduce stress-induced deaths in animals |
US4477469A (en) * | 1979-08-30 | 1984-10-16 | Herschler R J | Preparations containing methylsulfonylmethane and methods of use and purification |
US4616039A (en) * | 1979-08-30 | 1986-10-07 | Herschler R J | Methylsulfonylmethane in dietary products |
US5071878A (en) * | 1979-08-30 | 1991-12-10 | Herschler R J | Use of methylsulfonylmethane to enhance diet of an animal |
US4568547A (en) * | 1979-08-30 | 1986-02-04 | Herschler R J | Solid pharmaceutical compositions comprising MSM and their production |
JPH0740911B2 (ja) * | 1986-07-31 | 1995-05-10 | 麒麟麦酒株式会社 | 酵母入りビ−ル |
US4902517A (en) * | 1987-12-28 | 1990-02-20 | The Calpis Food Industry Co., Ltd. | Processes for producing milk-derived alcoholic beverages |
WO1994005272A1 (fr) | 1992-09-04 | 1994-03-17 | Aws Shakir Mustafa Salim | Compositions destinees au traitement de l'epiderme, contenant du dimethylsulfone et du dimethylsulfoxyde |
CN1069192C (zh) * | 1994-04-21 | 2001-08-08 | 王世立 | 一种气溶胶制剂及其配制方法 |
US5945425A (en) * | 1994-04-29 | 1999-08-31 | G.D. Searle & Co. | Method of using (H+ /K+)ATPase inhibitors as antiviral agents |
US5753696A (en) * | 1996-12-12 | 1998-05-19 | Cluster Technology Corp. | Compositions and methods for enhancement of dehydroepiandrosterone |
DE19735120A1 (de) * | 1997-08-13 | 1999-02-18 | Peter Hans Prof D Hofschneider | Verwendung von Thiolverbindungen zur Inaktivierung von Viren |
US6183758B1 (en) * | 1998-01-29 | 2001-02-06 | Highland Laboratories, Inc. | Phytochemicals, nutrients & medication absorption &/or treatment |
JP2003507437A (ja) * | 1999-08-26 | 2003-02-25 | ガネデン バイオテック, インコーポレイテッド | 抗真菌薬剤、抗細菌薬剤、および抗ウイルス薬剤のためのキャリアであるエミュー油の使用 |
WO2001073096A1 (fr) * | 2000-03-28 | 2001-10-04 | Cubist Pharmaceuticals, Inc. | Production amelioree de metabolites secondaires en presence d'additifs organiques |
CN1282577A (zh) * | 2000-05-31 | 2001-02-07 | 陈小川 | 二甲基亚砜在提高各类抗生素对细菌的敏感性等方面用途 |
US6440391B1 (en) * | 2000-06-02 | 2002-08-27 | Elstan Corporation | Management of snoring by oral administration of dimethyl sulfone |
GB2368012A (en) * | 2000-10-19 | 2002-04-24 | Nicholas John Larkins | Preparation for the relief of inflammatory disease |
US6328987B1 (en) * | 2000-11-03 | 2001-12-11 | Jan Marini Skin Research, Inc. | Cosmetic skin care compositions containing alpha interferon |
US6416772B1 (en) * | 2001-01-12 | 2002-07-09 | H. Wayne Van Engelen | Topical dermal anaesthetic |
JP3895224B2 (ja) * | 2001-12-03 | 2007-03-22 | 東京応化工業株式会社 | ポジ型レジスト組成物及びそれを用いたレジストパターン形成方法 |
US6579543B1 (en) * | 2002-02-22 | 2003-06-17 | Jackie H. McClung | Composition for topical application to skin |
US20040001817A1 (en) | 2002-05-14 | 2004-01-01 | Giampapa Vincent C. | Anti-aging nutritional supplement |
GB0212622D0 (en) * | 2002-05-31 | 2002-07-10 | Natural Technologies Group Ltd | Bacterial transforming agent |
US6776979B2 (en) * | 2002-12-30 | 2004-08-17 | Marvin B. Frager | Periodontal treatment compound and method of use |
EP1596872B1 (fr) * | 2003-01-24 | 2011-06-22 | Flora Technology Inc. | Compositions et procedes pour restaurer la flore bacterienne |
US7572473B2 (en) * | 2003-02-19 | 2009-08-11 | Franklin Foods, Inc. | Process for making yogurt cream cheese, and the resulting products |
US20040229825A1 (en) | 2003-05-13 | 2004-11-18 | Tomihiko Higuchi | Pharmaceutical composition for treatment of infection with drug resistant bacterium and disinfectant |
US20050118291A1 (en) * | 2003-09-10 | 2005-06-02 | Mian-Ying Wang | Formulations and methods for treating breast cancer with Morinda citrifolia and methylsulfonymethane |
US7351739B2 (en) * | 2004-04-30 | 2008-04-01 | Wellgen, Inc. | Bioactive compounds and methods of uses thereof |
ITBS20040068A1 (it) * | 2004-05-24 | 2004-08-24 | Gen Topics Srl | Composizione cosmetica e/o farmaceutica per il trattamento della rosacea |
US20060084573A1 (en) * | 2004-10-12 | 2006-04-20 | Biagro Western Sales, Inc. | High calcium fertilizer composition |
EP1906754A4 (fr) * | 2005-05-31 | 2009-03-11 | Limited Wockhardt | Nouveaux complements destines aux volailles et au betail |
US20070021376A1 (en) * | 2005-07-21 | 2007-01-25 | Suracell, Inc. | Supplement composition and method of use in enhancement of methylation process |
US8435224B2 (en) * | 2005-09-12 | 2013-05-07 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds |
US9265792B2 (en) * | 2005-11-16 | 2016-02-23 | Patricia A. Riley | Integument cell regeneration formulation |
WO2007134294A2 (fr) * | 2006-05-12 | 2007-11-22 | Arizona Board Of Regents, A Body Corporate Of The State Of Az Acting For & On Behalf Of Az State Unviversity | Nouvelle espèce chlorella et ses utilisations |
US20080038219A1 (en) * | 2006-08-07 | 2008-02-14 | Calgenex Corporation | Novel Composition for a Topical Skin Treatment Base and Medicated Applications Thereof |
US20080260708A1 (en) * | 2007-04-19 | 2008-10-23 | Hall Mickey A | Methods and related systems and formulations to normalize and improve human body chemistry and healing ability |
US7892724B2 (en) * | 2007-07-12 | 2011-02-22 | Warsaw Orthopedic, Inc | Method for enhancing the viability of mammalian cells, tissues and organs using a solution comprising two low molecular weight PEGs |
US7960098B2 (en) * | 2007-07-12 | 2011-06-14 | Warsaw Orthoperic, Inc. | Methods and compositions for the preservation of cells and tissues |
AP2011006001A0 (en) * | 2009-04-30 | 2011-12-31 | Bakteriefritt As | Composition for sterilizing surfaces. |
IT1393712B1 (it) * | 2009-05-13 | 2012-05-08 | Bruschettini Srl | Composizioni oftalmiche per la riepitelizzazione, la cicatrizzazione, e la disinfezione dei tessuti oculari |
JP5651186B2 (ja) * | 2009-10-30 | 2015-01-07 | バイオジェニック イノベーションズ, リミテッド ライアビリティ カンパニー | 薬剤耐性微生物を処置するためのメチルスルホニルメタン(msm) |
-
2010
- 2010-10-29 JP JP2012537140A patent/JP5651186B2/ja not_active Expired - Fee Related
- 2010-10-29 ES ES10827570.2T patent/ES2616630T3/es active Active
- 2010-10-29 MX MX2012005159A patent/MX2012005159A/es active IP Right Grant
- 2010-10-29 NZ NZ600145A patent/NZ600145A/en unknown
- 2010-10-29 AU AU2010313228A patent/AU2010313228B2/en not_active Ceased
- 2010-10-29 US US12/916,357 patent/US20110105623A1/en not_active Abandoned
- 2010-10-29 BR BR112012010270A patent/BR112012010270A2/pt not_active Application Discontinuation
- 2010-10-29 CN CN201080060119.8A patent/CN102724973B/zh not_active Expired - Fee Related
- 2010-10-29 NZ NZ600134A patent/NZ600134A/en not_active IP Right Cessation
- 2010-10-29 EP EP10827568.6A patent/EP2493464B8/fr not_active Not-in-force
- 2010-10-29 CA CA2778144A patent/CA2778144C/fr not_active Expired - Fee Related
- 2010-10-29 DK DK10827570.2T patent/DK2494059T3/en active
- 2010-10-29 CA CA2778142A patent/CA2778142C/fr not_active Expired - Fee Related
- 2010-10-29 ES ES10827568.6T patent/ES2674019T3/es active Active
- 2010-10-29 WO PCT/US2010/054837 patent/WO2011053848A1/fr active Application Filing
- 2010-10-29 KR KR1020127013999A patent/KR101826531B1/ko active IP Right Grant
- 2010-10-29 MX MX2014012070A patent/MX367373B/es unknown
- 2010-10-29 BR BR112012010272A patent/BR112012010272A2/pt not_active Application Discontinuation
- 2010-10-29 DK DK10827568.6T patent/DK2493464T3/en active
- 2010-10-29 SG SG10201500283UA patent/SG10201500283UA/en unknown
- 2010-10-29 CN CN201080060356.4A patent/CN102834520B/zh not_active Expired - Fee Related
- 2010-10-29 WO PCT/US2010/054845 patent/WO2011053854A1/fr active Application Filing
- 2010-10-29 US US12/916,365 patent/US20110152231A1/en not_active Abandoned
- 2010-10-29 JP JP2012537144A patent/JP2013509197A/ja active Pending
- 2010-10-29 EP EP10827570.2A patent/EP2494059B1/fr not_active Not-in-force
- 2010-10-29 AU AU2010281739A patent/AU2010281739B2/en not_active Ceased
- 2010-10-29 KR KR1020127014002A patent/KR101763560B1/ko active IP Right Grant
-
2011
- 2011-02-16 US US13/029,001 patent/US8841100B2/en active Active
-
2012
- 2012-02-17 US US13/399,921 patent/US8217085B2/en active Active
- 2012-04-12 US US13/445,831 patent/US20130065967A9/en not_active Abandoned
- 2012-04-19 IL IL219321A patent/IL219321A/en not_active IP Right Cessation
- 2012-04-19 IL IL219320A patent/IL219320A/en not_active IP Right Cessation
- 2012-05-02 MX MX2014012069A patent/MX353059B/es unknown
-
2013
- 2013-08-19 US US13/970,524 patent/US20130338130A1/en not_active Abandoned
-
2014
- 2014-08-12 US US14/458,148 patent/US9487749B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL219320A0 (en) | Use of methylsulfonylmethane (msm) to modulate microbial activity | |
EP2550244A4 (fr) | Traitement des déchets organiques | |
PL2362820T3 (pl) | Ułatwiające obrót elastyczne elementy do kontaktu ze skórą | |
EP2391623A4 (fr) | Inhibiteurs de l'activité d'akt | |
ZA201203289B (en) | Use of bethanechol for treatment of zerostomia | |
GB201015271D0 (en) | Improvements relating to wheelchairs | |
EP2413932A4 (fr) | Inhibiteurs de l'activité akt | |
GB201215219D0 (en) | Pyrolysis of biomass | |
EP2601279A4 (fr) | Supertorréfaction de biomasse en biocharbon | |
EP2405756A4 (fr) | Inhibiteurs de l'activité akt | |
HK1171013A1 (en) | Inhibitors of akt activity akt | |
EP2579872A4 (fr) | Inhibiteurs de l'activité akt | |
RS55027B1 (sr) | Upotreba sredstva za siliranje za tretiranje neusitnjene repe | |
EP2567356A4 (fr) | Recadrage des activités liées à l'état de préparation opérationnelle | |
WO2011109113A9 (fr) | Utilisation du bêta-nicotinamide adénine dinucléotide | |
ZA201203083B (en) | Use of methylsulfonylmethane (msm) to modulate microbial activity | |
IL214075A0 (en) | Use of pc for treatment follow up | |
AU2010902896A0 (en) | Treatment of plant biomass | |
AU2010902334A0 (en) | Treatment of organic waste | |
AU2010902914A0 (en) | Treatment of diabetes | |
AU2009904390A0 (en) | Provision of animal healthcare | |
AU2010901149A0 (en) | Metallurgic use of biomass | |
AU2009905081A0 (en) | Treatment of coal | |
TWM402708U (en) | Structure of coffin | |
TWM402707U (en) | Structure of coffin |